RxAnte - Crunchbase Company Profile & Funding

Q: Where is RxAnte's headquarters?

RxAnte is located in Portland, Maine, United States.

Q: Who invested in RxAnte?

RxAnte has 5 investors including Primus Capital Partners And Trinity Capital.

Q: When was the last funding round for RxAnte?

RxAnte closed its last funding round on obfuscated from a Private Equity round.

Overview

RxAnte

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About RxAnte

CB Rank

43011

RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.

Founded

obfuscation

Private

Private Equity

Portland, Maine, United States

51-100

www.rxante.com/

Analytics

Health Care

Medical

Pharmaceutical

Predictive Analytics

Funding Rounds

Private Equity

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Debt Financing

OBF

obfuscation

Key People

Joshua S. Benner: President & Chief Executive Officer
Past Role: Millennium Health, Vice President of Strategy & Corporate Development
Loren Lidsky: Co-Founder, SVP, Chief Analytics Officer, and Chief R&D Officer
Past Role: Pharmetrics, Director of Advanced Analytics

Details

Legal Name

RxAnte, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Aaron McKethan, Joshua S. Benner, Loren Lidsky

About the Company

RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members while

working with their prescribers and caregivers to make regimens safer, simpler, and more affordable.

Phone Number

703-288-0300

Contact Email

info@rxante.com

Predictions & Insights

Growth Insight

See this Growth Insight

RxAnte is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

RxEffect® Adherence Workflow Solution

A software platform that helps health plans identify, monitor, and manage members at risk of medication non-adherence through a prioritized daily workflow.

Value of Future Adherence (VFA) Software

An analytic tool that predicts the future medical cost impact of medication adherence for individual members to guide targeted pharmacy interventions.

Research & Development

RxAnte is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - RxAnte	1	obfuscated obfuscation	Primus Capital Partners	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Primus Capital Partners	Yes	Private Equity Round - RxAnte	Phillip Molner
Primus Capital Partners	Yes	Private Equity Round - RxAnte	Phillip Molner
Primus Capital Partners	Yes	Private Equity Round - RxAnte	Phillip Molner
Primus Capital Partners	Yes	Private Equity Round - RxAnte	Phillip Molner
Primus Capital Partners	Yes	Private Equity Round - RxAnte	Phillip Molner